CTLA-4 Blockade with Monoclonal Antibodies in Patients with Metastatic Cancer: Surgical Issues

被引：0
|
作者：
Giao Q. Phan
Jeffrey S. Weber
Vernon K. Sondak
机构：
[1] H. Lee Moffitt Cancer Center,Division of Cutaneous Oncology
[2] H. Lee Moffitt Cancer Center,The Donald A. Adam Comprehensive Melanoma Research Center
[3] University of South Florida College of Medicine,Department of Oncologic Sciences
[4] University of South Florida College of Medicine,Department of Surgery
来源：
Annals of Surgical Oncology | 2008年 / 15卷
关键词：
Immune-related Adverse Events (IRAEs); Ipilimumab; Tremelimumab; Hypophysitis; Infliximab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3014 / 3021
页数：7
相关论文
共 50 条
  • [21] Cracking the Stone: Combination Vaccination and CTLA-4 Blockade in Pancreatic Cancer
    Bajor, David L.
    Vonderheide, Robert H.
    JOURNAL OF IMMUNOTHERAPY, 2013, 36 (07) : 362 - 364
  • [22] CTLA-4 blockade: Unveiling immune regulation
    Dranoff, G
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (04) : 662 - 664
  • [23] A pilot study of CTLA-4 blockade after cancer vaccine failure in patients with advanced malignancy
    O'Mahony, Deirdre
    Morris, John C.
    Quinn, Cate
    Gao, Wendy
    Wilson, Wyndham H.
    Gause, Barry
    Pittaluga, Stefania
    Neelapu, Sattva
    Brown, Margaret
    Fleisher, Thomas A.
    Gulley, James L.
    Schlom, Jeffrey
    Nussenblatt, Robert
    Albert, Paul
    Davis, Thomas A.
    Lowy, Israel
    Petrus, Mike
    Waldmann, Thomas A.
    Janik, John E.
    CLINICAL CANCER RESEARCH, 2007, 13 (03) : 958 - 964
  • [24] CTLA-4 Blockade with Ipilimumab: Long-term Follow-up of 177 Patients with Metastatic Melanoma
    Prieto, Peter A.
    Yang, James C.
    Sherry, Richard M.
    Hughes, Marybeth S.
    Kammula, Udai S.
    White, Donald E.
    Levy, Catherine L.
    Rosenberg, Steven A.
    Phan, Giao Q.
    CLINICAL CANCER RESEARCH, 2012, 18 (07) : 2039 - 2047
  • [25] Sequencing CTLA-4 blockade with cell-based immunotherapy for prostate cancer
    Satoshi Wada
    Christopher M Jackson
    Kiyoshi Yoshimura
    Hung-Rong Yen
    Derese Getnet
    Timothy J Harris
    Monica V Goldberg
    Tullia C Bruno
    Joseph F Grosso
    Nicholas Durham
    George J Netto
    Drew M Pardoll
    Charles G Drake
    Journal of Translational Medicine, 11
  • [26] IDO blockade negatively regulates the CTLA-4 signaling in breast cancer cells
    Azimnasab-Sorkhabi, Parviz
    Soltani-Asl, Maryam
    Yoshinaga, Tulio Teruo
    Massoco, Cristina de Oliveira
    Kfoury Junior, Jose Roberto
    IMMUNOLOGIC RESEARCH, 2023, 71 (05) : 679 - 686
  • [27] IDO blockade negatively regulates the CTLA-4 signaling in breast cancer cells
    Parviz Azimnasab-sorkhabi
    Maryam Soltani-asl
    Túlio Teruo Yoshinaga
    Cristina de Oliveira Massoco
    Jose´ Roberto Kfoury Junior
    Immunologic Research, 2023, 71 : 679 - 686
  • [28] CTLA-4 blockade after allo-SCT
    David Killock
    Nature Reviews Clinical Oncology, 2016, 13 (9) : 530 - 530
  • [29] Improved survival with gemcitabine and CTLA-4 blockade in a murine model of prostate cancer
    Ariyan, Charlotte E.
    Quezada, Segio
    Corse, Emily
    Montalvo, Welby
    Allison, James
    CANCER RESEARCH, 2011, 71
  • [30] Sequencing CTLA-4 blockade with cell-based immunotherapy for prostate cancer
    Wada, Satoshi
    Jackson, Christopher M.
    Yoshimura, Kiyoshi
    Yen, Hung-Rong
    Getnet, Derese
    Harris, Timothy J.
    Goldberg, Monica V.
    Bruno, Tullia C.
    Grosso, Joseph F.
    Durham, Nicholas
    Netto, George J.
    Pardoll, Drew M.
    Drake, Charles G.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2013, 11
12345